Page 22 - Platform Technology News Today

/PRNewswire/ -- Sinoveda is a revolutionary health-science brand that is changing the way consumers can approach health and wellness. As one of seven Canadian...

/PRNewswire/ -- The health and wellness industry is currently suffering from an excess of pain relief options. From dangerously strong NSAIDs to highly...

/PRNewswire/ -- Sinoveda is a revolutionary health-science brand that is changing the way consumers can approach health and wellness. As one of seven Canadian...

AMSTERDAM, Nov. 16, 2022 /PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug

14.11.2022 - Continued Progress in Pepinemab Oncology and Neurology Clinical ProgramsPromising initial responses in Phase 1b/2 open-label KEYNOTE B84 study of pepinemab with KEYTRUDA in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patient ...

/PRNewswire/ -- BioSymetrics, a phenomics-driven AI drug discovery company, today announced that John Baldoni will join its strategic advisory board. John is a...

Aptabios Isuzinaxib (APX-115) proves its effect on a key kidney function marker in a Phase 2 clinical study in patients with diabetes and chronic kidney...

/PRNewswire/ -- Sinoveda is a Canadian-based health-science brand that is blazing an innovative trail toward the future of healthcare. The company has...

Synaffix obtains exclusive rights to the CliCr technology, to combine with its proprietary ADC platform technology CliCr further expands the repertoire of payloads suitable for conjugation by

/PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of...